OCTOBER PHARMA S.A.E |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100 EGP | 0.00% |
|
0.00% | 0.00% |
| Mar. 10 | October Pharma S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | October Pharma S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| Sales 2022 | 727M 15.25M | Sales 2023 | 1.01B 21.21M | Capitalization | 1.2B 25.16M |
|---|---|---|---|---|---|
| Net income 2022 | 131M 2.75M | Net income 2023 | 182M 3.82M | EV / Sales 2022 | 2.08 x |
| Net Debt 2022 | 316M 6.62M | Net Debt 2023 | 279M 5.84M | EV / Sales 2023 | 1.46 x |
| P/E ratio 2022 |
10.6
x | P/E ratio 2023 |
7.98
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.51% |
More Fundamentals
* Assessed data
More news
1 week
94.02
100.00
1 month
91.03100.00
Current year
86.41109.99
1 year
80.00110.00
3 years
45.00120.00
5 years
29.71120.00
10 years
15.50120.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Tamer Ahmed
DFI | Director of Finance/CFO | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 18-10-30 | |
| Director/Board Member | - | - | |
| Chief Executive Officer | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 100 | 0.00% | 0 |
| 24-04-23 | 100 | 0.00% | 2 |
End-of-day quote Egyptian Exchange, April 23, 2024
More quotes
October Pharma S.A.E. specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of cardiovascular, diabetic, gastroenterological, inflammatory, infectious, metabolic, viral, urological, gynecological, dermatological, dental diseases, etc.
At the end of 2020, the group had a production site located in Egypt.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 25.05M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- OCPH Stock
